BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ - Get Free Report)'s share price fell 3.6% during trading on Monday . The stock traded as low as $1.60 and last traded at $1.61. 31,664 shares traded hands during trading, a decline of 100% from the average session volume of 62,169,492 shares. The stock had previously closed at $1.67.
BioRestorative Therapies Stock Performance
The company has a market capitalization of $2.72 billion, a PE ratio of -1.55 and a beta of 102.36. The company has a 50 day moving average price of $1.75 and a 200 day moving average price of $1.75.
BioRestorative Therapies Company Profile
(
Get Free Report)
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company's two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Stories
Before you consider BioRestorative Therapies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioRestorative Therapies wasn't on the list.
While BioRestorative Therapies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
